In lung adenocarcinoma (LAC), KRAS and vascular endothelial growth factor (VEGF) receptor, NRP2, trigger MAPK/ERK/Gli1 signaling cascade to promote tumor progression (38). The gene discussed is KRAS; the disease is neoplasm.